Research and Markets: Onartuzumab (Non-Small Cell Lung Cancer) - Forecast ... The Herald | HeraldOnline.com Sales forecast for Onartuzumab for the top nine countries from 2012 to 2022. - Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan, India and China. Key Topics Covered: 1.1 List of Tables. 1.2 List of Figures. 2 Introduction. |
